Loading…
Biocon is investing $100 million in a new fermentation-based active pharmaceutical ingredient (API) production facility in Visakhapatnam, India. The facility is scheduled to be commissioned by the end of 2021.
| Site | Largest | Latest |
|---|---|---|
| Visakhapatnam, India | $100.0M | 2020-04-07 |